|
"The path to new drugs, while tedious, provides new scientific and business opportunities"
Tue., September 23, 2008 | 3pm-4:30pm | San Jose, CA
Ving Lee, PhD - Senior Vice President, Research, Limerick BioPharma - has devoted many years to the discovery of new anti-infectives. He will discuss how revisiting old natural products, with defined endpoints for clinical needs, provides potential commercial opportunities; examples from the discovery of new tetracyclines, beta-lactams for problematic Gram-positive pathogens, and uridyl peptide antibiotics will be highlighted. He will also discuss how observations from the above work led to a component of the technology platform of Limerick Biopharm Inc.
Click here for speaker's bio and to read more about this event»
Space is limited for this event, therefore please register early to secure your spot.
Regular Price: $30
Partners' Network: $20
BioCenter Members: Free (please RSVP to Aurιlie)
On-site Registration, if space allows: add $10 to the above
Venue
The San Jose BioCenter 5941 Optical Court San Jose, CA 95138
Click here for Venue Directions»
Upcoming BioCenter Program
The Joys and Sorrows of Quantitation in Mass Spectrometry, Particularly in Relation to DMPK : Perspectives from a Power User, Contract Laboratory, and Instrument Manufacturer | Fri., Sep. 12, 2008
Three Bay Area leaders in mass spectrometry have been invited to present their viewpoints on the rapidly expanding field of mass spectrometry and DMPK. Special attention will be paid to the challenges, opportunities, and rewards that confront and confound users that require quantitation. Bill Fitch, Principal Research Scientist, Roche Pharmaceutical Research, Bob Cunico, President, Bay Bioanalytical Laboratory, Inc., and Rohan Thakur, Marketing Director, Small Molecule Solutions, ThermoFisher Scientific, will address the issues of mass spectrometry, DMPK, and quantitation from their unique perspective.
Read more»
Meet with... the National Cancer Institute SBIR Development Center [NIH part I] | Wed., Sep. 17, 2008
In this session, Directors from the NCI SBIR Development Center will talk to current and potential grantees about the Small Business Innovation Research (SBIR) Phase II Bridge Award and other opportunities such as their contract topics.
After the presentation, each attendee will be granted a private meeting with Mr. Michael Weingarten the Director of the NCI SBIR Development Center and/or Dr. Ali Andalibi the Program Director of the NCI SBIR Development Center.
Read More»
Overcoming M&A; Challenges - Planning a Good Deal and Your Exit | Thu., Sep. 18, 2008
The past few years have seen a significant increase in M&A; activity in the life sciences industry. Join this panel to hear M&A; strategy perspective from the acquirer and the acquired, the investor, and the lawyer. You will learn: How to identify the good target buyer, and how to approach him; Valuation challenges and strategies; How to structure the deal; What to expect after the acquisition; What are the relative advantages of pursuing a M&A; over other transactions; What are the risks and how to mitigate these risks; How to plan a successful exit; etc.
Read more»
New Reforms in Patent Law | Wed., Oct. 1, 2008
Liz Howard, of Orrick, will present a summary of the latest developments from the Federal Circuit, and the Supreme Court, in patent law.
Included will be a discussion of case law relating to
what constitutes inequitable conduct in obtaining patents,
what constitutes willful infringement,
when licensing "exhausts" your patent rights going forward,
how courts are now evaluating "obviousness" of a patent in deciding patent validity,
and the latest word on the question of patentable subject matter.
Dr. Howard will also discuss the potential impact of these trends on patent drafting strategies, as well as on licensing strategies. The session will also include ample opportunity for questions and answers from the audience.
Read More»
Partner Events
Overcoming high clearance and poor bioavailability - September 10, 2008 - a CACO-BAADME joint workshop - Foster City, California
Fifth Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology and Pharmaceutical Industries - September 10-12, 2008 - a CASSS conference - Napa, California
Investments in Biofuels - September 11, 2008 - a BayBio Institute Venture Spotlight event - Palo Alto, California
Biotech Supply Chain Academy - September 11-12, 2008 - an ESCA conference - San Francisco, California
The Joys and Sorrows of Quantitation in Mass Spectrometry, Particularly in Relation to DMPK : Perspectives from a Power User, Contract Laboratory, and Instrument Manufacturer - September 12, 2008 an "All About Science" event hosted by the BioCenter and organized by The San Francisco Bay Area Mass Spectrometry (BAMS) discussion group - San Jose, California
From Strategy to Execution: Growing Your Company to the Next Level - September 15, 2008 - a FountainBlue life science entrepreneurs' forum - Palo Alto, California
Labs21 2008 Annual Conference - September 16-18, 2008 - a I²SL conference - San Jose, California
Meet with... the National Cancer Institute SBIR Development Center [NIH part I] - September 17, 2008 a BioCenter "Meet with..." event - San Jose, California
Overcoming M&A; Challenges - Planning a Good Deal and Your Exit - September 18, 2008 a BioCenter Industry Panel - Menlo Park, California
Site Seeing in the World of Regulatory Affairs - September 19, 2008 - a CACO seminar & luncheon - Foster City, California
31st International Ion Chromatography Symposium - September 21-24, 2008 - a CASSS conference - Portland, OR
Bugs & Drugs - September 22-23, 2008 a GTCbio conference - San Diego, California
The Chemistry of Drugs: The path to new drugs, while tedious, provides new scientific and business opportunities - September 23, 2008 a BioCenter ChemFusion event - San Jose, California
Gene Acres 2008 - September 24, 2008 - a BayBio conference - South San Francisco, California
Global Clinical Trial Operations - September 25-26, 2008 a GTCbio conference - San Diego, California
Biomarker Discovery Summit 2008 - September 29-October 1, 2008 a Cambridge Healthtech Institute conference - Philadelphia, PA
IP & Regulatory workshop: New Reforms in Patent Law - October 1, 2008 a BioCenter IP & Regulatory event - Menlo Park, California
BioCenter Open House Tour - October 1, 2008 a BioCenter event - San Jose, California
Biomarker Discovery Europe 2008 - October 2-3, 2008 a GTCbio conference Dublin, Ireland
BioExec Institute 2008 - Oct. 8-9 | Nov. 3-4 | Dec. 8-9, 2008 - a UC Berkeley Center for Executive Development class in collaboration with the BioCenter & produced by Deloitte & Touche USA LLP
Neurodgenerative Diseases Drug Discovery - October 9-10, 2008 a GTCbio conference - Philadelphia, PA
IP & Regulatory workshop: IP Audit - October 15, 2008 a BioCenter IP & Regulatory event - San Jose, California
4th Modern Drug Discovery and Development Summit (M3D) - October 15-17, 2008 a GTCbio conference - San Diego, California
9th Annual Early Stage Venture Capital Investing - October 22, 2008 an International Business Forum conference - San Francisco, California
Medicinal Chemistry for Oncology: Case Studies from Big Pharma - October 23, 2008 a BioCenter ChemFusion event - San Jose, California
Sixth Annual Life Sciences Investor & Entrepreneur Roundtables - October 28, 2008 - a BayBio Institute event - Palo Alto, California
IP & Regulatory workshop: Document Management - October 29, 2008 a BioCenter IP & Regulatory event- San Jose, California
IP & Regulatory workshop: Regulatory Compliance - November 12, 2008 a BioCenter IP & Regulatory event- San Jose, California
BIO-Europe 2008 - November 17-19, 2008 - an EBD conference - Mannheim/Heidelberg, Germany
7th Annual it Conference - November 19-21, 2008 - an Astia conference - San Francisco, California
5th Annual Optimising Biomanufacturing Processes 2008 - December 2-3, 2008 - a VIBevents conference - Brussels, Belgium
11th Annual Corporate Venturing & Strategic Investing Conference - January 19-20,2009 an International Business Forum conference - Palm Springs, California
Molecular Medicine Tri Conference - February 24-27, 2009 a Cambridge Healthtech Institute conference - San Francisco, California
BioCenter Expansion: Reserve Your Lab Now!
The BioCenter recently kicked off the expansion to 80,000sf with second stage lab spaces of 5,000 10,000 sf. Applications to reserve lab spaces are now available. If youd like to be considered as a BioCenter company, please click and fill in the application form. The BioCenter does not take any IP or equity stakes. Our goal is to level the playing field for small companies by providing the same type of infrastructure that project teams in large companies have access to. For more information, please contact Gayle Fagan at [email protected] or 408.960.3805.
Review the BioCenter Services Offering»
Review our Criteria»
|
|